Metactive Medical Announces Name Change to Artio Medical

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

Metactive Medical, Inc., a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today that it has changed its name to Artio Medical, Inc. effective immediately.

“The corporate name change marks an important milestone as we progress toward commercialization,” said F. Nicholas Franano, MD, President and CEO of Artio Medical. “Artio is a Latin word meaning to place with a tight fit, which aligns with our strategy to design medical devices for precision placement and a hand-to-glove fit.”

Artio Medical was founded in 2014 as a small R&D group focused on developing metal implants for vascular embolization. The organization has since grown to include a team of exceptionally talented medical device professionals and expanded its focus to include flexible polymer implants to address a wide range of clinical needs and market opportunities, including artery, vein, and vascular aneurysm embolization. In conjunction with the corporate name change, the company has unveiled its new logo and website.

Artio Medical also announced new names for their portfolio of peripheral vascular and neurovascular embolization products under development, including:

  • Solus Gold™ Embolization Device for peripheral vascular embolization
  • Solus Flex™ Embolization Device for peripheral vascular embolization
  • Aneura™ Embolization Coils for peripheral aneurysm embolization
  • Aneura™ Embolization Device for peripheral aneurysm embolization
  • Endura™ Embolization Coils for cerebral aneurysm embolization
  • Endura™ Embolization Device for cerebral aneurysm embolization
spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.